Bayram, HaleDönmez Çakıl, YaprakSitar, Mustafa ErincDemirel, GamzeSelam, BelginCincik, Mehmet2024-07-122024-07-1220232075-172910.3390/life130308152-s2.0-85151356464https://doi.org/10.3390/life13030815https://hdl.handle.net/20.500.12415/6946Chemotherapeutic agents used in the treatment of testicular cancer cause damage to healthy tissues, including the testis. We investigated the effects of glutathione on sperm DNA integrity and testicular histomorphology in bleomycin etoposide cisplatin (BEP) treated rats. Twelve-week-old male rats of reproductive age (n = 24) were randomly divided into three groups, the (i) control group, (ii) BEP group, and (iii) BEP+ glutathione group. Weight gain increase and testes indices of the control group were found to be higher than that of the BEP group and BEP+ glutathione group. While the BEP treatment increased sperm DNA fragmentation and morphological abnormalities when compared to the control group, GSH treatment resulted in a marked decrease for both parameters. Moreover, BEP treatment significantly decreased serum testosterone levels and sperm counts in comparison to the control group, yet this reduction was recovered in the BEP+ glutathione treated group. Similarly, seminiferous tubule epithelial thicknesses and Johnsen scores in testicles were higher in the control and BEP+ glutathione groups than in the BEP-treated group. In conclusion, exogenous glutathione might prevent the deterioration of male reproductive functions by alleviating the detrimental effects of BEP treatment on sperm quality and testicular histomorphology.eninfo:eu-repo/semantics/openAccessBleomycinChemotherapyCisplatinDna FragmentationEtoposideGlutathioneSpermatozoaArticle336983969Q213WOS:000959051200001N/A